For the fiscal year ending March 2026, net sales reached \u00a51,107.0 billion (up 1% YoY), adjusted operating profit was \u00a5143.3 billion (operating profit margin 14.2%, down 4.7pp YoY), and net income attributable to owners of the parent was \u00a524.8 billion (down 40% YoY). For the full year ending March 2027, net sales are expected to be between \u00a51.055 trillion and \u00a51.076 trillion, with an operating profit margin of 15.2% to 16.7%. <\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7733","jir_company_name":"Olympus Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-05-12","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/7733-20260512-02.pdf","jir_short_summary":"For the fiscal year ending March 2026, net sales reached \u00a51,107.0 billion (up 1% YoY), adjusted operating profit was \u00a5143.3 billion (operating profit margin 14.2%, down 4.7pp YoY), and net income attributable to owners of the parent was \u00a524.8 billion (down 40% YoY). For the full year ending March 2027, net sales are expected to be between \u00a51.055 trillion and \u00a51.076 trillion, with an operating profit margin of 15.2% to 16.7%. ","jir_summary":"### Overview of Consolidated Results for Fiscal Year Ending March 2026\nFor the fiscal year ending March 2026, net sales reached \u00a51,107.0 billion, a 1% increase YoY, but adjusted operating profit declined YoY to \u00a5143.3 billion, with an operating profit margin of 14.2%, down 4.7 points from the previous year. Net income attributable to owners of the parent was \u00a524.8 billion, a decrease of 40% YoY. The primary factors for the profit margin decline include FDA-related import warnings and voluntary shipment suspensions (approximately \u00a530 billion), headwinds from U.S. tariffs, poor sales mix, and one-time restructuring expenses. The Medical Systems (GIS) division performed well across North America, Europe, and Asia-Pacific, with sales of \u00a5210.1 billion, up 16% YoY (adjusted for currency effects, +10%). The Surgical Imaging Systems (SIS) division rebounded to growth following the resumption of urology product shipments, while respiratory and other therapy areas continue to be affected by shipment suspensions, but these impacts are under control.\n\n### 2027 Year-End Performance Outlook and Growth Strategy\nFor the fiscal year ending March 2027, net sales are projected to be between \u00a51.055 trillion and \u00a51.076 trillion, with an adjusted operating profit margin of 15.2% to 16.7%. The foreign exchange-adjusted sales growth rate is expected to be 1.5% to 3.5%, with an operating profit margin improvement of 1.0pp to 2.5pp. In FY2027, Olympus plans to repurchase up to \u00a560 billion of shares and aims to maintain a stable dividend of 30 yen per share. The company will continue investments in innovation, strengthen its GIS platform, and pursue strategic M&A, launching over ten new products. Olympus will shift from a dividend-centric shareholder return framework to a balanced approach of dividends and share buybacks, enhancing profitability and capital efficiency.","jir_financial_highlights":"Net Sales: \u00a51,107.0 billion (Up 1% YoY)\nAdjusted Operating Profit: \u00a5143.3 billion (Decreased YoY (Operating profit margin 14.2%, down 4.7pp YoY))\nNet Income Attributable to Owners of Parent: \u00a524.8 billion (Down 40% YoY)\nAdjusted EPS: 36 yen (Down 11% YoY)\nSales Forecast for March 2027: \u00a51.055 trillion to \u00a51.076 trillion (Up 4.4% to 6.5% YoY)\nAdjusted Operating Profit Margin Forecast for March 2027: 15.2% to 16.7% (Up 1.0pp to 2.5pp YoY)\nSales after Forex Adjustment YoY for March 2027: +1.5% to +3.5% (Unknown)\nOperating Profit Margin after Forex Adjustment YoY for March 2027: +1.0pp to +2.5pp (Unknown)","jir_category":"","jir_hashtags":"#Olympus, #FinancialResults, #EarningsOutlook, #JapaneseStocks","jir_key_figures":"Fiscal Year Ending March 2026 Net Sales: \u00a51,107.0 billion (up 1% YoY)\nFiscal Year Ending March 2026 Adjusted Operating Profit: \u00a5143.3 billion (Operating profit margin 14.2%, down 4.7pp YoY)\nFiscal Year Ending March 2026 Net Income Attributable to Owners of Parent: \u00a524.8 billion (down 40% YoY)\nForecast for March 2027 Net Sales: \u00a51.055 trillion to \u00a51.076 trillion (up 4.4% to 6.5% YoY)\nForecast for March 2027 Adjusted Operating Profit Margin: 15.2% to 16.7% (up 1.0pp to 2.5pp YoY)\nShare buyback planned for March 2027: up to \u00a560 billion\nDividend per share for March 2027: \u00a530 (maintained)","jir_meta_title":"\u3010Olympus\u3011Fiscal Year Ending March 2026 Financial Results\uff5cNet Sales \u00a51,107.0 billion (up 1%)","jir_meta_description":"Olympus Corporation's consolidated financial results for the fiscal year ending March 2026 show net sales of \u00a51,107.0 billion, adjusted operating profit of \u00a5143.3 billion, and net income of \u00a524.8 billion. The full-year outlook for March 2027 predicts net sales of \u00a51.055 trillion to \u00a51.076 trillion with an operating profit margin of 15.2% to 16.7%.","jir_og_title":"\u3010Olympus\u3011Fiscal Year Ending March 2026 Financial Results\uff5cNet Sales \u00a51,107.0 billion (+1%)","jir_og_description":"Olympus released its fiscal year ending March 2026 results and outlook for 2027. Net sales reached \u00a51,107.0 billion with an operating profit margin of 14.2%. The company aims for accelerated growth in 2027.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[]","ir_related_company":6918,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-48262","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n